|
Rankings
for week of April 2, 2012 (VDSI, SCLN, VELT, WNC, PKT) 
We have one new addition to our Emerging Growth rankings this week.
Vasco Data Security (VDSI #23) sells hardware and software
used for authenticating a person's identity. Its system generates "one-time"
passwords and digital signatures that protect transactions. Its two main markets
are banking (78% of revenue) and authenticating remote workers to access
corporate networks (22%). After a tough start in 1H11, VDSI saw a significant
increase in large deals in 2H11, especially on the banking side. Orders have
been brisk and VDSI is rolling out a cloud platform, which is thinks will be
successful. A potential concern is VDSI's heavy exposure to Europe as the EMEA
region accounts for 66% of revenue, but management says its business there is
holding up. Finally, VDSI has a strong balance sheet with $84.5 million in
cash/investments, or $2.20 per share, with no LT debt.
* *
*
- SciClone Pharma (SCLN): A Fast-Growing US drug company with a unique focus
on China (3/29/12)
- Wabash National (WNC): Makes acquisition that gets them in new markets and
should boost margins (3/27/12)
- Procera Networks (PKT): Announces a follow-on order, shows it can compete
for Tier-1 customers (3/27/12)
- Sturm Ruger (RGR): Seeing a big increase in orders but appears to be driven
by inventory restocking (3/22/12)
- On Assignment (ASGN): Makes a highly accretive deal which boosts its IT
staffing business (3/21/12)
- Best Performing Emerging Growth Stocks for 2009-2012 (3/19/12)
- Constant Contact (CTCT): Not just an email marketing company anymore
(3/15/12)
- Acquisition History: ZOLL becomes the 24th acquisition of an EG component
(3/12/12)
- Emerging Growth Stocks User's Guide (1/20/12)
Notes for today's deletions:
- CPE: Relative Strength drops down to 64.
- FUL: Reported a good quarter last Wednesday, and RS is
still very strong (currently 93). But the Q4 sales growth rate of just 11%
does not compare well to other faster-growing names in our universe, which
pushed FUL's rank below #100.
 SciClone
Pharma (SCLN): A Fast-Growing US drug company with a unique focus on
China...Published to Live In Play on March 29
One of the more intriguing new names to debut on Emerging Growth Stocks
recently is SciClone Pharmaceuticals (SCLN). SciClone is a small US-based
specialty pharma company that does 97% of its sales inside China.
To get an idea of how big that market is becoming, SciClone estimates that
the Chinese pharmaceuticals market should grow 15-20% annually over the next few
years, and should become the #2 pharmaceutical market in the world by 2016.
While the Chinese pharma market is slowing down along with the economy, it is
still growing far faster than the more mature markets in the West, and SciClone
in turn is growing faster than the Chinese pharma market as a whole.
 Velti
(VELT): A potential play on Millennial Media IPO...Published to
Live In Play on March 29
Millennial Media (MM), which operates an advertising platform for mobile
apps, is making a big splash with its IPO debut today. It priced at $13, opened
at $25 and is now above $26.
A potential play on this is Velti (VELT), which was just added to our
Emerging Growth rankings on Monday. It provides a technology platform which
enables customers (large mobile operators and ad agencies) to market products on
mobile devices. VELT, which runs 4,000+ campaigns/year, is benefitting from high
barriers to entry, is expanding aggressively in the US (Europe accounts for 2/3
of revs) and should benefit from an expected influx of mobile ad spending in
coming years (consumers spend 10% of their time on mobile devices but only 1% of
ad budgets currently spent on mobile). The stock jumped in mid-March on a
surprisingly strong Q4 report.
 Wabash
National (WNC): Makes acquisition that gets them in new markets and
should boost margins...Published to Live In Play on March 27
Wabash National, which has made a nice move since being added to our rankings
on
January 11 at $8.90 (+26%), is gapping up 14% today on an acquisition. With
that kind of move, you'd think WNC is getting acquired but that's not the case.
Instead, WNC is buying another company that should boost margins significantly.
For some quick background, Wabash National sounds like it could be a bank,
but it's not. It's one of the largest manufacturers of semi trailers in North
America. It sells dry freight vans, refrigerated vans, flatbed trailers, drop
deck trailers, truck bodies and intermodal equipment.
 Procera
Networks (PKT): Announces a follow-on order, shows it can compete for
Tier-1 customers...Published to Live In Play on March 27
Procera Networks, which has been one of our biggest winners since joining our
rankings on
November 2 at $11.36 (+96%), announced a follow-on order this morning. It
wasn't a huge order but it was pretty big for them and perhaps more importantly
it shows that their platform is showing some success with Tier-1 operators.
For some quick background, Procera Networks sells deep packet inspection
(DPI) devices sold under the brand name PacketLogic. Its network management
equipment monitors network traffic, optimizes bandwidth, identifies security
threats, and manages application usage. PKT considers itself entirely a software
company as it partners with hardware vendors to create the hardware portion of
the device then ships it to customers. Customers include cable operators (58% of
revenue), fixed line operators (24%), mobile operators (3%), higher education
(9%) and service/support (6%).
All times ET.
- Monday, April 2: None.
- Tuesday, April 3: None.
- Wednesday, April 4: SNTS
is presenting at Needham Healthcare Conference at 10am ET; RAX
is presenting at Wells Fargo Tech Summit at 7:30pm ET.
- Thursday, April 5: MPEL
annual meeting, no time provided.
- Friday, April 6:
Holiday, market closed.
The following table contains a list of stocks that we believe have the
potential to become market leaders. EG components are derived from a
quantitative screen and ranking system that is designed to uncover small- to
mid-cap companies that possess a combination of superior 6-month Relative
Strength, strong top- and bottom-line growth rates, and expanding margins (among
other factors). There are no valuation criteria applied to this list.
Companies in the rankings are sorted by Relative Strength, in descending
order.
|
Emerging Growth: April 2, 2012 |
|
New Buy List: Top 25 |
| 1 |
Velti |
VELT |
|
$13.46 |
|
Industry: |
IT Services |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $837 |
750 |
51 |
9% |
67% |
99 |
700% |
-27% |
52% |
3% |
|
Date Added & Original Profile: |
3/26/2012 |
Price Added: |
$13.62 |
% Gain/Loss |
-1% |
Most Recent Analysis: |
-- |
| VELT provides
a technology platform which enables customers (large mobile
operators and ad agencies) to market products on mobile devices.
VELT, which runs 4,000+ campaigns/yr, is benefitting from high
barriers to entry, is expanding aggressively in the US (Europe
accounts for 2/3 of revs) and should benefit from an expected influx
of mobile ad spending in coming years (consumers spend 10% of their
time on mobile devices but only 1% of ad budgets currently spent on
mobile). The stock jumped in mid-March on a surprisingly strong Q4
report. However, its business is highly seasonal as a loss is
expected in Q1. |
| 2 |
Pozen Inc. |
POZN |
|
$6.15 |
|
Industry: |
Pharmaceuticals |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $180 |
271 |
21 |
4% |
97% |
99 |
234% |
-- |
151% |
7775% |
|
Date Added & Original Profile: |
3/26/2012 |
Price Added: |
$5.56 |
% Gain/Loss |
11% |
Most Recent Analysis: |
-- |
| POZN is a
small biotech co focusing on aspirin therapies designed to enable
the full power of aspirin by reducing its GI damage. Phase 3 results
for its leading candidate (PA32540) were announced on March 22 and
an NDA filing is expected in 3Q12. Of note, POZN is not profitable.
It reported a profit in 4Q11 only because it sold its royalty rights
for its migraine drug (Treximet) to a Canadian pension fund for $75
mln (stock jumped in Nov 2011 on the news). A loss is expected in Q1
which will cause it to drop from our rankings. Bal sheet is in great
shape with $120 mln in cash ($4/sh) and no LT debt. |
| 3 |
Arctic Cat |
ACAT |
|
$42.62 |
|
Industry: |
Recreational Products |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $542 |
243 |
6 |
5% |
97% |
99 |
84% |
57% |
36% |
14% |
|
Date Added & Original Profile: |
2/6/2012 |
Price Added: |
$33.87 |
% Gain/Loss |
26% |
Most Recent Analysis: |
-- |
| ACAT is a
maker of snowmobiles, ATVs, and related accessories that has
achieved a major turnaround and returned to growth after reporting 2
very strong qtrs. The co has refreshed its product line, gained
share, reduced inventories, raised margins, and strengthened its
balance sheet. The new Wildcat side-by-side vehicle is selling
particularly well, along with its accompanying high-mgn accessories.
ACAT recently bought out Suzuki's stake in the co, reducing ACAT
shares out by one-third, to 12 mln shares. |
| 4 |
Pharmacyclics |
PCYC |
|
$28.00 |
|
Industry: |
Biotechnology |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $1,910 |
861 |
55 |
10% |
95% |
99 |
#700% |
-- |
2659% |
2569% |
|
Date Added & Original Profile: |
2/13/2012 |
Price Added: |
$24.81 |
% Gain/Loss |
13% |
Most Recent Analysis: |
3/2/2012 |
| PCYC is a
development-stage biopharma co with three product candidates in
clinical trials. One of its more promising is PCI-32765, which is
being co-developed with JNJ for lymphoma and leukemia. Multiple
Phase III trials will be launched over the next several years,
starting in mid-2012. Keep in mind that PCYC does not have any
product revenue; however it did report a DecQ profit in mid-Feb that
was from a large one-time milestone payment from JNJ, so PCYC could
revert to losses in future qtrs. Of note, should PCI-32765 get
approved, PCYC stands to get another $1 bln in milestone payments. |
| 5 |
Zoll Medical |
ZOLL |
|
$92.65 |
|
Industry: |
Medical Specialties |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $2,064 |
548 |
22 |
3% |
99% |
99 |
61% |
14% |
18% |
1% |
|
Date Added & Original Profile: |
12/19/2011 |
Price Added: |
$61.87 |
% Gain/Loss |
50% |
Most Recent Analysis: |
3/12/2012 |
| ZOLL, a
supplier of cardiac defibrillators, announced on March 12 that it
agreed to be acquired by Japanese chemical producer Asahi Kasei for
$93/sh in cash. This represents a 50% premium from where it entered
our rankings. Both boards have approved the merger, which is
expected to close in 2Q12. Its flagship product is the LifeVest, the
world's only wearable automatic defibrillator. It seems odd that a
chemical co would buy a medical device co, but Asahi Kasei has been
branching into other areas and it sees healthcare as a key growth
driver. The deal should accelerate ZOLL's growth in Asia. |
| 6 |
Santarus |
SNTS |
|
$6.00 |
|
Industry: |
Pharmaceuticals |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $358 |
428 |
55 |
5% |
102% |
98 |
#200% |
13% |
65% |
3% |
|
Date Added & Original Profile: |
3/19/2012 |
Price Added: |
$5.29 |
% Gain/Loss |
13% |
Most Recent Analysis: |
-- |
| SNTS is a
specialty pharma co that looks set to finally achieve steady,
profitable growth. It sells Glumetza and Cycloset to treat Type 2
diabetes. Zegerid, for GI diseases, had been a big revenue driver
until the co lost a patent case in April 2010 which opened the door
to generic competition. SNTS added a fourth drug in Dec 2011 when it
licensed Fenoglide from Shore Pharma. Upcoming catalysts include an
appeals court decision on Zegerid (near term), an Oct 16 PDUFA date
for its Uceris drug to treat colitis (FDA accepted NDA in mid-Feb)
and clinical milestones (two are in Phase 3 trials). |
| 7 |
On Assignment |
ASGN |
|
$17.85 |
|
Industry: |
Personnel Services |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $653 |
307 |
24 |
3% |
98% |
98 |
150% |
29% |
34% |
2% |
|
Date Added & Original Profile: |
2/21/2012 |
Price Added: |
$14.05 |
% Gain/Loss |
27% |
Most Recent Analysis: |
3/21/2012 |
| ASGN is a
professional staffing firm that announced a transformative
acquisition on March 21 causing the stock to jump 27% that day. ASGN
will acquire privately-held Apex Systems, the sixth largest IT
staffing firm in the US. It’s a highly accretive deal with very
little overlap and it significantly boosts ASGN’s exposure to the
rapidly growing IT space (ASGN currently has a high exposure to
healthcare). Apex is actually larger than ASGN ($700 mln in revs vs.
$600 mln for ASGN). Temporary staffing stocks have been doing well
as more employers embrace temporary labor in an uncertain economic
climate. |
| 8 |
American Vanguard |
AVD |
|
$22.16 |
|
Industry: |
Chemicals |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $599 |
202 |
14 |
9% |
102% |
98 |
64% |
53% |
36% |
14% |
|
Date Added & Original Profile: |
3/19/2012 |
Price Added: |
$20.34 |
% Gain/Loss |
9% |
Most Recent Analysis: |
-- |
| AVD is a
supplier of ag chemicals like pesticides, plant-growth regulators,
herbicides, and soil fumigants. AVD has consistently grown its top
and bottom lines over the past 2 years on rising demand,
particularly its granular corn soil insecticides, and on the
successful integration of strategic acquisitions, such as Bayer
CropScience in 2H10. This strong demand has also allowed the company
to run its plants at higher capacity utilization rates, which has
spread fixed costs over a larger base and expanded margins. In all,
AVD is play on rising commodity costs. |
| 9 |
LeapFrog |
LF |
|
$8.53 |
|
Industry: |
Recreational Products |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $463 |
831 |
39 |
4% |
100% |
98 |
29% |
15% |
11% |
3% |
|
Date Added & Original Profile: |
2/21/2012 |
Price Added: |
$7.51 |
% Gain/Loss |
14% |
Most Recent Analysis: |
3/16/2012 |
| LF makes toys
for kids, but with a focus on educational toys. It sells many toys,
but its two standouts are the LeapPad (there have been many
iterations but the latest version launched in mid-2011 in a touch
tablet format has been a big seller) and the Leapster Explorer
(handheld device, similar to the Sony PSP). LF is a seemingly
perpetual turnaround play, but the very strong Q4 results reported
in early Feb are convincing investors that mgmt has fixed its
inventory problems and that its product platform (especially the new
LeapPad and its downloadable apps) is finally a winner. |
| 10 |
eResearch Tech |
ERT |
|
$7.87 |
|
Industry: |
Health Svcs |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $385 |
233 |
36 |
3% |
99% |
98 |
17% |
27% |
16% |
11% |
|
Date Added & Original Profile: |
3/12/2012 |
Price Added: |
$6.80 |
% Gain/Loss |
16% |
Most Recent Analysis: |
-- |
| ERT provides
technology-based services for biopharmas, CROs, & medical device
companies that improve the accuracy, timeliness, & efficacy of
clinical trials. Its rev is mainly derived from fees generated
through its Cardiac Safety & Respiratory lines. ERT recently
achieved record qtrly revs, bookings, & backlog driven by increased
Phase III trial activity from large pharmas, as well as by record
contributions from its German operations. Also, ERT believes it has
taken mkt share & its recent launch of two new products, MasterScope
& EXPERT 3, gives it capacity to take on more concurrent trials. |
| 11 |
Procera Networks |
PKT |
|
$22.25 |
|
Industry: |
Computer Comms |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $329 |
246 |
13 |
11% |
95% |
97 |
650% |
181% |
108% |
39% |
|
Date Added & Original Profile: |
11/2/2011 |
Price Added: |
$11.36 |
% Gain/Loss |
96% |
Most Recent Analysis: |
3/27/2012 |
| PKT sells
devices that monitor network traffic, optimize bandwidth, identify
security threats etc. Customers include cable operators and wireline/mobile
carriers. It's in the same space as FFIV, RVBD, ALLT, BCSI. Despite,
its smaller size, PKT says "when we compete, we in" and it's taking
market share. PKT is benefitting from the 4G rollout and customers
looking to better monetize their networks to increase revs. A
concern is high customer concentration, but the co has 18 trials
underway. |
| 12 |
VOXX Intl |
VOXX |
|
$13.32 |
|
Industry: |
Telecom Equipment |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $282 |
240 |
16 |
6% |
91% |
97 |
129% |
28% |
27% |
3% |
|
Date Added & Original Profile: |
2/13/2012 |
Price Added: |
$14.18 |
% Gain/Loss |
-6% |
Most Recent Analysis: |
-- |
| VOXX, which
sells electronic products for car & home use, has been a decade-long
turnaround story. However, 3Q12 results reported in Jan suggest the
co's turnaround might finally be gaining traction. Co is still
focused mostly on products for the car and home, but VOXX is
shifting its mix from the low-end towards higher-mgn smartphone/tablet
products, high-end audio systems, and accessories. Mgmt's focus is
now on profitability, and they are willing to walk away from deeply
discounted sales in order to protect mgns. Despite 3 qtrs of solid
growth, VOXX still trades at a low-teens multiple. |
| 13 |
Select Comfort |
SCSS |
|
$32.49 |
|
Industry: |
Home Furnishings |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $1,829 |
1,093 |
47 |
10% |
96% |
97 |
108% |
21% |
27% |
4% |
|
Date Added & Original Profile: |
10/24/2011 |
Price Added: |
$21.42 |
% Gain/Loss |
52% |
Most Recent Analysis: |
2/13/2012 |
| SCSS is a
specialty, higher-end mattress retailer. Its bed use air chambers to
provide a gentle cushion of support which can be adjusted to
preference for comfort and firmness. SCSS is a turnaround name that
has seen its new marketing, rebranding (now Sleep Number
mattresses), and retail growth strategies pay off with double-digit
top and bottom line growth over the past few qtrs. With less than 5%
of the US market share, management sees its brand as still largely
underpenetrated. |
| 14 |
Allot Comms |
ALLT |
|
$23.45 |
|
Industry: |
Computer Comms |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $696 |
399 |
12 |
1% |
99% |
97 |
100% |
12% |
36% |
5% |
|
Date Added & Original Profile: |
3/19/2012 |
Price Added: |
$20.32 |
% Gain/Loss |
15% |
Most Recent Analysis: |
-- |
| ALLT sells
deep packet inspection (DPI) hardware & software that prioritizes
and reroutes Internet traffic, balances server loads etc. DPI helps
mobile carriers contend with the increasing flood of data and it
allows them to charge data hogs more. Optimization alone can save up
to 30% of bandwidth which lets carriers delay buying more routers,
which can cost up to 5x more than DPI. A catalyst is that while ALLT
is already big in Europe (no slowdown there despite debt problems),
it should finally start to see revs from US mobile operators.
They've been slow to adopt, but 2012 should mark a turning point. |
| 15 |
SciClone Pharma |
SCLN |
|
$6.22 |
|
Industry: |
Biotechnology |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $365 |
297 |
44 |
7% |
89% |
96 |
163% |
56% |
75% |
0% |
|
Date Added & Original Profile: |
3/19/2012 |
Price Added: |
$6.48 |
% Gain/Loss |
-4% |
Most Recent Analysis: |
3/29/2012 |
| SCLN is a
commercial-stage US-based biotech with a specific focus on China.
The co's flagship drug is Zadaxin, which has been approved in China
and 30+ other countries for the treatment of Hepatitis B & C and
other indications. It’s a similar story to JAZZ in that SCLN had
been a one-product co until it made a transformative acquisition. In
April 2011 SCLN bought Chinese co Novamed, which gave it 18 marketed
drugs in China, bolstered its pipeline, and greatly expanded its
footprint in China. Aside from upcoming approvals, more recent
catalysts include the ongoing stock buyback and the discontinuation
of SCV-07 (which will remove a drag on profitability). |
| 16 |
Shuffle Master |
SHFL |
|
$17.94 |
|
Industry: |
Casinos/Gaming |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $967 |
588 |
54 |
3% |
98% |
96 |
56% |
25% |
28% |
16% |
|
Date Added & Original Profile: |
2/13/2012 |
Price Added: |
$14.43 |
% Gain/Loss |
24% |
Most Recent Analysis: |
3/12/2012 |
| SHFL makes a
variety of gaming and casino products (card shufflers, slot
machines, table games). Recent revenue and EPS growth isn't
explosive, but SHFL has been growing consistently at low double
digit rates, which outpaces its peer group. Also, it generates a
high level of recurring revenue due to slot machine replacement
cycles. A number of catalysts could enhance its growth, such as the
possibility of legalized online betting in the US and its entrance
into Latin American mkts. |
| 17 |
Sourcefire |
FIRE |
|
$48.50 |
|
Industry: |
Software |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $1,402 |
640 |
25 |
19% |
96% |
96 |
47% |
28% |
40% |
13% |
|
Date Added & Original Profile: |
2/27/2012 |
Price Added: |
$45.00 |
% Gain/Loss |
8% |
Most Recent Analysis: |
3/14/2012 |
| FIRE provides
network security software for businesses and the government. It is
best known for its commercial Intrusion Prevention System offering,
as well as for its open-source network security products. FIRE
enters the rankings following blowout Q4 results on 2/21. Over the
past 3 qtrs, revenues have accelerated, earnings growth has resumed,
and margins have expanded as the co’s turnaround efforts have begun
to take hold. FIRE’s growth has been driven by a restructured sales
force that has expanded the co’s distribution partners and new
product rollouts including FirePOWER, its next gen firewall. |
| 18 |
DUSA Pharma |
DUSA |
|
$6.23 |
|
Industry: |
Biotechnology |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $154 |
191 |
15 |
6% |
91% |
96 |
33% |
23% |
27% |
10% |
|
Date Added & Original Profile: |
3/26/2012 |
Price Added: |
$6.46 |
% Gain/Loss |
-4% |
Most Recent Analysis: |
-- |
| DUSA develops
therapies for pre-cancerous skin lesions ("actinic keratoses"),
which are caused by sun exposure and affect ~58 mln Americans. The
co's drug treatment, Levulan Kerastick, is applied to the skin, and
the drug is activated by the co's BLU-U light equipment. It's a
razor/razorblade model: 95% of revs come from recurring Levulan
Kerastick sales, with 5% coming from BLU-U. Mgmt says DUSA has only
penetrated 6% of the ~$750 mln US mkt, and has patent protection
until 2019. While DUSA's 2Q11 & 3Q11 reports were underwhelming,
4Q11 results were strong and DUSA received favorable 2012
reimbursement rates vs other treatments. |
| 19 |
United Rentals |
URI |
|
$42.84 |
|
Industry: |
Finance/Rental |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $2,735 |
1,907 |
47 |
31% |
98% |
95 |
413% |
41% |
25% |
8% |
|
Date Added & Original Profile: |
11/21/2011 |
Price Added: |
$24.80 |
% Gain/Loss |
73% |
Most Recent Analysis: |
1/25/2012 |
| URI is the
world's largest commercial and construction equipment renter with
541 locations in the US and Canada. It offers items ranging from
heavy construction equipment like backhoes to general tools like
pressure washers. URI is taking share from smaller rental outfits
that make up the bulk of the industry, but have suffered from a lack
of capital and downsized fleets in the wake of the recession. URI is
also benefitting from a secular trend towards renting, rather than
buying. |
| 20 |
RailAmerica |
RA |
|
$21.40 |
|
Industry: |
Railroads |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $1,084 |
225 |
19 |
4% |
95% |
95 |
94% |
56% |
15% |
7% |
|
Date Added & Original Profile: |
3/26/2012 |
Price Added: |
$22.47 |
% Gain/Loss |
-5% |
Most Recent Analysis: |
-- |
| RA operates 43
short line railroads (ranging from 4 to 625 miles each), which haul
goods from facilities in rural areas then connect those cars up to
the national railway where Class I carriers take them from there.
Short line railroads, in virtually all cases, are the only provider
of rail service at a customer location and they have more
predictable operations. RA concedes its business has been hurt by
the recession but it expects to increase carloads in 2012 for the
first time in years. Growth is coming from encouraging cos to build
near their railroads, acquisitions and high margin non-freight
revenue. |
| 21 |
Sturm Ruger & Co. |
RGR |
|
$50.87 |
|
Industry: |
Recreational Products |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $940 |
303 |
19 |
11% |
101% |
95 |
80% |
17% |
45% |
14% |
|
Date Added & Original Profile: |
8/3/2011 |
Price Added: |
$27.77 |
% Gain/Loss |
83% |
Most Recent Analysis: |
3/22/2012 |
| RGR designs,
manufactures, and sells of firearms primarily to domestic customers.
Co offers guns in 4 major industry categories -- rifles, shotguns,
pistols, and revolvers. RGR's firearms are sold through independent
wholesale distributors like CAB, principally to the U.S. commercial
sporting market. Export sales represent less than 6% of firearms
sales. RGR also manufactures and sells castings made from steel
alloys for both outside customers and internal use in the firearms
segment. |
| 22 |
Eagle Materials |
EXP |
|
$34.55 |
|
Industry: |
Construction Materials |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $1,562 |
656 |
39 |
6% |
93% |
95 |
67% |
61% |
19% |
9% |
|
Date Added & Original Profile: |
2/6/2012 |
Price Added: |
$32.67 |
% Gain/Loss |
6% |
Most Recent Analysis: |
-- |
| EXP is a
provider of building materials, such as cement, gypsum wallboard &
paperboard. Given its exposure to a soft residential construction
mkt, & the fact that it's a commodity business, it's surprising to
see EXP on our list. But, a mix of modestly higher demand & prior
cost cutting measures has led to much-improved financial results.
Cement volume improvements (primarily due to a mild winter), low
natural gas prices, & price increases for wallboard products have
been other key drivers. |
| 23 |
Vasco Data Security |
VDSI |
 |
$10.76 |
|
Industry: |
IT Services |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $413 |
268 |
19 |
3% |
73% |
95 |
65% |
107% |
47% |
15% |
|
Date Added & Original Profile: |
4/2/2012 |
Price Added: |
$10.76 |
% Gain/Loss |
0% |
Most Recent Analysis: |
-- |
| VDSI sells
hardware and software used for authenticating a person's identity.
Its system generates "one-time" passwords and digital signatures
that protect transactions. Its two main mkts are banking (78% of
revs) and authenticating remote workers to access corporate networks
(22%). After a tough start in 1H11, VDSI saw an increase in large
deals in 2H11, especially on the banking side. Orders have been
brisk and VDSI is rolling out a cloud platform. A potential concern
is heavy exposure to the EMEA (66% of revs) region, but business is
holding up. VDSI has $84.5 mln in cash ($2.20/sh) with no LT debt. |
| 24 |
Fossil |
FOSL |
|
$133.25 |
|
Industry: |
Consumer Specialties |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $8,155 |
1,173 |
41 |
8% |
98% |
95 |
28% |
6% |
18% |
-1% |
|
Date Added & Original Profile: |
3/12/2012 |
Price Added: |
$128.45 |
% Gain/Loss |
4% |
Most Recent Analysis: |
-- |
| FOSL designs
and sells an extensive line of men's and women's watches and
jewelry, and has recently started selling higher margin accessories
such as handbags, small leather goods, belts, sunglasses, etc. In
addition to continuing strong demand for watches & fashion
accessories, the co has been benefitting from very strong sales of
Michael Kors- and Armani Exchange-branded products (which FOSL
actually manufacturers). Q4 sales & guidance were disappointing, and
the big Q4 EPS beat was almost completely due to a lower tax rate,
but investors seem to be bidding FOSL up (aided by high short
interest) as a "KORS play." |
| 25 |
Multimedia Games |
MGAM |
|
$11.02 |
|
Industry: |
Casinos/Gaming |
| Market Cap (mln) |
Avg Vol (000) |
Float (mln) |
Short Int. |
Price vs High |
6-Mo RS |
Q EPS % |
Q EPS Beat |
Q Rev % |
Q Rev Beat |
| $297 |
302 |
25 |
4% |
95% |
94 |
#380% |
282% |
22% |
12% |
|
Date Added & Original Profile: |
2/6/2012 |
Price Added: |
$10.09 |
% Gain/Loss |
9% |
Most Recent Analysis: |
3/9/2012 |
| MGAM is a
supplier of slot machines to casinos with a high exposure to Indian
tribes. Rather than just selling machines, MGAM focuses more on
getting an ongoing percentage after installation. MGAM gets 75% of
its revs this way (recurring and high mgn), the highest % among all
publicly-traded manufacturers. MGAM is expanding its footprint to
more states and recently re-signed a key deal with Chickasaw Nation.
A surprisingly strong DecQ report in late Jan has been the catalyst
for the recent move. |
|
Holds: Ranks #26-100 |
|
Rank |
Name |
Ticker |
Industry |
Mkt Cap |
6-Mo RS |
Q EPS % |
Q Rev % |
Date Added |
% Gain/Loss |
| #26 |
Aceto |
ACET |
Chemicals |
$254 |
94 |
113% |
29% |
-- |
-- |
|
#27 |
Qihoo 360 |
QIHU |
Internet Software |
$837 |
93 |
400% |
214% |
3/26/2012 |
-3% |
| #28 |
HealthStream |
HSTM |
Health Svcs |
$603 |
93 |
40% |
24% |
2/27/2012 |
5% |
|
#29 |
Zumiez |
ZUMZ |
Apparel/Footwear |
$1,126 |
93 |
22% |
18% |
-- |
-- |
| #30 |
Zoltek |
ZOLT |
Industrial |
$389 |
92 |
#660% |
43% |
-- |
-- |
|
#31 |
H&E Equipment |
HEES |
Commercial Services |
$664 |
92 |
#429% |
24% |
3/12/2012 |
-5% |
| #32 |
Perfect World |
PWRD |
Recreational
Products |
$686 |
92 |
142% |
37% |
3/26/2012 |
-1% |
|
#33 |
LinkedIn |
LNKD |
Internet Software |
$4,338 |
92 |
100% |
105% |
-- |
-- |
| #34 |
Bio-Reference |
BRLI |
Health Svcs |
$653 |
92 |
53% |
23% |
3/12/2012 |
3% |
|
#35 |
Buffalo Wild Wings |
BWLD |
Restaurants |
$1,668 |
92 |
33% |
34% |
3/5/2012 |
2% |
| #36 |
Wellcare |
WCG |
Managed Health Care |
$3,080 |
91 |
203% |
18% |
-- |
-- |
|
#37 |
Aegean Marine |
ANW |
Oil & Gas Pipelines |
$319 |
91 |
#158% |
20% |
2/27/2012 |
-3% |
| #38 |
CoreSite Realty |
COR |
IT Services |
$468 |
91 |
#106% |
20% |
-- |
-- |
|
#39 |
Tangoe |
TNGO |
IT Services |
$685 |
91 |
100% |
57% |
3/12/2012 |
7% |
| #40 |
Calumet
Specialty |
CLMT |
Industrial |
$1,361 |
91 |
92% |
71% |
-- |
-- |
|
#41 |
Rackspace |
RAX |
Internet Software |
$7,778 |
91 |
80% |
32% |
-- |
-- |
| #42 |
Protective Life |
PL |
Insurance |
$2,419 |
91 |
65% |
7% |
1/9/2012 |
28% |
|
#43 |
lululemon |
LULU |
Apparel/Footwear |
$8,299 |
91 |
59% |
51% |
-- |
-- |
| #44 |
Parametric |
PMTC |
Software |
$3,328 |
91 |
59% |
19% |
1/30/2012 |
12% |
|
#45 |
Tempur-Pedic |
TPX |
Home Furnishings |
$5,402 |
91 |
27% |
25% |
-- |
-- |
| #46 |
Wabash National |
WNC |
Trucks/Construction |
$707 |
90 |
263% |
41% |
1/11/2012 |
16% |
|
#47 |
Cirrus Logic |
CRUS |
Semiconductors |
$1,525 |
90 |
26% |
28% |
3/5/2012 |
4% |
| #48 |
Web.com |
WWWW |
Internet Software |
$700 |
90 |
17% |
64% |
1/23/2012 |
14% |
|
#49 |
WisdomTree |
WETF |
Investment Managers |
$1,031 |
89 |
#200% |
21% |
-- |
-- |
| #50 |
SVB Financial |
SIVB |
Regional Banks |
$2,817 |
89 |
98% |
21% |
3/19/2012 |
-4% |
|
#51 |
Coinstar |
CSTR |
Consumer Services |
$1,967 |
89 |
47% |
33% |
-- |
-- |
| #52 |
SXC Health |
SXCI |
Health Svcs |
$4,676 |
89 |
71% |
162% |
-- |
-- |
|
#53 |
PerkinElmer |
PKI |
Medical Specialties |
$3,139 |
89 |
41% |
18% |
-- |
-- |
| #54 |
Melco Crown |
MPEL |
Casinos/Gaming |
$7,516 |
88 |
567% |
30% |
-- |
-- |
|
#55 |
Terex |
TEX |
Trucks/Construction |
$2,471 |
88 |
#224% |
47% |
1/30/2012 |
12% |
| #56 |
Beacon Roofing |
BECN |
Distributors |
$1,195 |
88 |
77% |
21% |
-- |
-- |
|
#57 |
Ulta Salon |
ULTA |
Specialty Stores |
$5,803 |
88 |
49% |
23% |
-- |
-- |
| #58 |
Chico's FAS |
CHS |
Apparel/Footwear |
$2,528 |
88 |
25% |
20% |
-- |
-- |
|
#59 |
Zillow |
Z |
Consumer Services |
$704 |
87 |
#250% |
107% |
-- |
-- |
| #60 |
GNC Holdings |
GNC |
Food
Retail |
$3,724 |
87 |
106% |
17% |
-- |
-- |
|
#61 |
Mitek Systems |
MITK |
IT Services |
$286 |
87 |
#150% |
151% |
3/12/2012 |
-3% |
| #62 |
W.R. Grace |
GRA |
Chemicals |
$4,274 |
87 |
44% |
19% |
-- |
-- |
|
#63 |
Chart Industries |
GTLS |
Industrial Machinery |
$2,173 |
87 |
42% |
38% |
-- |
-- |
| #64 |
Netease.com |
NTES |
Internet Software |
$7,609 |
87 |
31% |
35% |
-- |
-- |
|
#65 |
SolarWinds |
SWI |
Software |
$2,799 |
87 |
21% |
34% |
3/5/2012 |
3% |
| #66 |
Fuel Systems |
FSYS |
Automotive Aftermarket |
$524 |
86 |
#450% |
34% |
-- |
-- |
|
#67 |
MarketAxess |
MKTX |
Investment Banks |
$1,343 |
86 |
26% |
17% |
-- |
-- |
| #68 |
Trimble
Navigation |
TRMB |
Telecom Equipment |
$6,788 |
86 |
17% |
35% |
-- |
-- |
|
#69 |
Kenexa |
KNXA |
Software |
$851 |
86 |
17% |
28% |
-- |
-- |
| #70 |
Hornbeck
Offshore |
HOS |
Oilfield Services |
$1,472 |
85 |
350% |
26% |
2/27/2012 |
0% |
|
#71 |
Liquidity Services |
LQDT |
Consumer Services |
$1,373 |
85 |
118% |
35% |
-- |
-- |
| #72 |
Gaylord Ent. |
GET |
Hotels/Resorts |
$1,495 |
85 |
#114% |
26% |
-- |
-- |
|
#73 |
Constant Contact |
CTCT |
Commercial Services |
$900 |
85 |
80% |
21% |
1/18/2012 |
16% |
| #74 |
Salix Pharma |
SLXP |
Pharmaceuticals |
$3,120 |
85 |
79% |
31% |
-- |
-- |
|
#75 |
Western Alliance |
WAL |
Regional Banks |
$704 |
84 |
#141% |
22% |
3/19/2012 |
-6% |
| #76 |
Methanex |
MEOH |
Chemicals |
$3,033 |
84 |
127% |
22% |
-- |
-- |
|
#77 |
Emulex |
ELX |
Computer Comms |
$897 |
84 |
73% |
13% |
1/30/2012 |
0% |
| #78 |
Wright Express |
WXS |
Commercial Services |
$2,504 |
84 |
32% |
22% |
-- |
-- |
|
#79 |
Jones Lang LaSalle |
JLL |
Real Estate |
$3,634 |
84 |
32% |
20% |
-- |
-- |
| #80 |
VeriFone
Systems |
PAY |
IT
Services |
$5,535 |
84 |
35% |
50% |
-- |
-- |
|
#81 |
Spirit Airlines |
SAVE |
Airlines |
$1,359 |
83 |
74% |
27% |
-- |
-- |
| #82 |
Susquehanna |
SUSQ |
Regional Banks |
$1,856 |
83 |
50% |
27% |
-- |
-- |
|
#83 |
Mellanox |
MLNX |
Semiconductors |
$1,675 |
83 |
48% |
79% |
-- |
-- |
| #84 |
Old Dominion |
ODFL |
Trucking |
$2,738 |
82 |
77% |
22% |
-- |
-- |
|
#85 |
Impax Laboratories |
IPXL |
Pharmaceuticals |
$1,642 |
82 |
75% |
55% |
-- |
-- |
| #86 |
Approach
Resources |
AREX |
Oil &
Gas |
$1,231 |
82 |
46% |
91% |
10/31/2011 |
50% |
|
#87 |
Abiomed |
ABMD |
Medical Specialties |
$865 |
81 |
#450% |
18% |
2/13/2012 |
-6% |
| #88 |
Body Central |
BODY |
Apparel |
$468 |
81 |
111% |
20% |
-- |
-- |
|
#89 |
Bankrate |
RATE |
Financial Publishing |
$2,475 |
81 |
90% |
47% |
-- |
-- |
| #90 |
Wesco |
WCC |
Distributors |
$2,838 |
81 |
56% |
19% |
1/30/2012 |
3% |
|
#91 |
Hain Celestial |
HAIN |
Food: |
$1,943 |
81 |
33% |
32% |
-- |
-- |
| #92 |
InnerWorkings |
INWK |
Commercial Printing |
$548 |
80 |
71% |
34% |
-- |
-- |
|
#93 |
Madison Square Garden |
MSG |
Movies/Entertainment |
$2,128 |
80 |
83% |
64% |
-- |
-- |
| #94 |
Titan Machinery |
TITN |
Specialty Stores |
$586 |
80 |
45% |
36% |
-- |
-- |
|
#95 |
Landstar System |
LSTR |
Trucking |
$2,697 |
80 |
40% |
22% |
-- |
-- |
| #96 |
Mindray Medical |
MR |
Medical Specialties |
$2,818 |
80 |
15% |
25% |
-- |
-- |
|
#97 |
D.R. Horton |
DHI |
Homebuilding |
$4,807 |
79 |
#250% |
15% |
-- |
-- |
| #98 |
Lithia Motors |
LAD |
Specialty Stores |
$580 |
79 |
129% |
29% |
-- |
-- |
|
#99 |
Pegasystems |
PEGA |
IT Services |
$1,443 |
79 |
129% |
29% |
-- |
-- |
| #100 |
Align
Technology |
ALGN |
Medical Specialties |
$2,187 |
79 |
100% |
39% |
-- |
-- |
- Lead Analyst & Developer of the Emerging Growth system: Jim Busch
- Fundamental Analysts: Robert Reid; Dennis Hobein; Jeff Eckmann; Chris
Borgmeyer, CFA
- Technical Analyst: Jon Henninger
|
